Tracing the Untraceable
It is almost the one year anniversary of when COVID-19 was discovered in Wuhan, China. As a fellow Canadian, this past year has shown me how fast this deadly disease can spread. I won’t ever forget how I watched global communitirs went on lockdown overnight. I thought to myself, it was only a matter of time that other countries needed to learn how to track the spread of the disease.
Everyday, I was reading up on the newest developments of the coronavirus. There was one story that caught my eye. South Korea and Taiwan managed to test a vast majority of their citizens quickly for the coronavirus. For a disease so new to the rest of the world, it was not foreign for these 2 countries. Both have a history of dealing with SARS and MERS. This time with COVID-19, their contract tracing system was able to identify those who were affected and isolate them.
This diagnostic systems is key to advancing medical solutions to COVID-19. Still, there are many people in low income countries that do not have access to these diagnostics. As of now, the rest of the world is focusing on developing a vaccine. Canada must continue in investing in diagnostic tools to help control COVID-19 everywhere.
Canada must invest at least 1% of its COVID-19 response in new and additional aid towards and emergency global response to end the pandemic everywhere. A significant portion of this must go to global health agencies delivering on the ACT-Accelerator (ACT-A) diagnostics pillar. The ACT-A aims to develop essential health products and services and ensures that these new technologies are given to the ones that need them most.
A pandemic is best solved when everyone is on the same playing field. Canada and the rest of the world must ensure that everyone has equal access to diagnostic tools and treatments to end COVID-19.